Why Medtech Is Still Decades Behind Fintech with Esther Reynal

In this episode, your host Henry Norton is joined by Esther Reynal de St Michel Richardot, Founding Partner at THENA Capital, to discuss why so many medtech founders are building technologies without understanding their real market challenges and how early-stage thinking about value propositions and stakeholder needs can make or break a healthcare startup. Esther… Continue reading Why Medtech Is Still Decades Behind Fintech with Esther Reynal

Building Acquisition-Ready Medtech from Series A with Gautam Kainth

In this episode, host Henry Norton sits down with Gautam Kainth, Partner at TCP Health Ventures, to unpack why medtech investing fundamentally differs from traditional tech and what founders need to know about positioning their companies for strategic exits. Gautam brings over 20 years of investment experience with $1+ billion in deployed capital across 30+… Continue reading Building Acquisition-Ready Medtech from Series A with Gautam Kainth

Vivasure Exits to Haemonetics for €185 Million, an Interview with Andrew Glass

In this episode of The Crux of MedTech, host Henry Norton sits down with Andrew Glass, CEO of Vivasure Medical, fresh off announcing the company’s acquisition by Haemonetics Corporation. Andrew shares the full journey, from his early days in drug-eluting stents at Guidant (later Abbott), to running a $10M sales territory, to making equity investments… Continue reading Vivasure Exits to Haemonetics for €185 Million, an Interview with Andrew Glass